Study on Pregnant Women with Inflammatory Bowel Disease Receives Funding

Uma Mahadevan, MD, at the University of California, San Francisco, Center for Colitis and Crohn's Disease was awarded a clinical research grant to complete a study of pregnancy outcomes in women with inflammatory bowel disease (IBD) from the Foundation for Clinical Research in IBD.

(PRWEB) November 20, 2004 -- Uma Mahadevan, MD, at the University of California, San Francisco, Center for Colitis and Crohn's Disease was awarded a clinical research grant to complete a study of pregnancy outcomes in women with inflammatory bowel disease (IBD) from the Foundation for Clinical Research in IBD.

The study is the first population-based analysis specifically addressing the questions of immunosuppressive medications and disease activity in IBD, during the conception and pregnancy and their effect on the mother and baby.

The study group was drawn from the three million members of the Northern California Kaiser Permanente (NCKP) health plan who became pregnant between 1994-2002. "We have identified 493 women with IBD who were pregnant and matched them with 493 controls without IBD," says Dr. Mahadevan. "At this time, 314 cases and 432 controls have been abstracted. We have also completed 300 telephone questionnaires."

Once completed, the study will expand existing knowledge of conception and pregnancy in IBD patients, providing guidelines and reasonable risk assessment for care.

For more information about this study and about the Foundation, visit the Foundation's Web site at http://www.clinicalresearchinibd.org.

###